natgillin/translations-raw huggingface dataset:
If a radiolabelled test substance is used (to measure total mineralisation), specific chemical analyses can be made in parallel to provide useful additional information and check the procedure.
Če se uporabi radioaktivno označena preskusna snov (za merjenje skupne mineralizacije), se lahko vzporedno opravijo specifične kemijske analize, ki dajo uporabne dodatne podatke in s katerimi se preverja postopek. Specifične kemijske analize se lahko tudi uporabijo za merjenje produktov transformacije, ki nastanejo med razgradnjo preskusne snovi.
The concentration of the test substance and the transformation products at every sampling time should be measured and reported (as a concentration and as percentage of applied).
Koncentracijo preskusne snovi in produktov transformacije je treba pri vsaki ponovitvi vzorčenja izmeriti in o njej poročati (o koncentraciji in o uporabljenem odstotku).
In general, transformation products detected at ≥ 10 % of the applied concentration at any sampling time should be identified unless reasonably justified otherwise.
Na splošno je treba ugotoviti produkte transformacije, ki se pri katerem koli vzorčenju zaznajo pri ≥ 10 % uporabljene koncentracije, razen če ni upravičeno utemeljeno drugače.
Transformation products for which concentrations are continuously increasing during the study should also be considered for identification, even if their concentrations do not exceed the limit given above, as this may indicate persistence.
Tudi produkte transformacije, pri katerih se koncentracije med raziskavo nenehno povečujejo, je treba upoštevati pri ugotavljanju, tudi če njihove koncentracije ne presegajo zgornje omejitve, ker lahko označujejo obstojnost.
Analyses of transformation products in sterile controls should be considered, if rapid abiotic transformation of the test substance (e.g. hydrolysis) is thought possible.
Če je možno, da se preskusna snov hitro abiotsko pretvarja (npr. s hidrolizo), je treba preučiti izvedbo analiz produktov transformacije v sterilnih kontrolnih vzorcih.
The need for quantification and identification of transformation products should be considered on a case by case basis, with justifications being provided in the report.
Potrebo po količinski opredelitvi in določevanju produktov transformacije je treba upoštevati glede na vsak primer posebej in v poročilu podati utemeljitev.
Extraction techniques with organic solvent should be applied according to directions given in the respective analytical procedure.
Tehnike ekstrakcije z organskim topilom je treba uporabiti po navodilih v ustreznem analitičnem postopku.
All samples should be stored at 2 to 4 °C and air-tight if analysis is carried out within 24 hours (preferred).
Če se analiza opravi v 24 urah (prednostno), je treba vse vzorce shranjevati pri 2 do 4 °C in zrakotesno.
For longer storage, the samples should be frozen below – 18 °C or chemically preserved.
Če je shranjevanje daljše, je treba vzorce zamrzniti pod –18 °C ali kemijsko konzervirati.
Acidification is not a recommended method to preserve the samples, because acidified samples may be unstable.
Zakisanje ni priporočljiva metoda konzerviranja vzorcev saj so lahko zakisani vzorci neobstojni.
If the samples are not analysed within 24 hours and are subject to longer storage, a storage stability study should be conducted to demonstrate the stability of chemicals of interest under – 18 °C storage or preserved conditions.
Če se vzorci ne analizirajo v 24 urah in so shranjevani dlje, je treba opraviti raziskavo obstojnosti med shranjevanjem, da se dokaže obstojnost želenih kemikalij med shranjevanjem pri –18 °C ali v pogojih konzerviranja.
If the analytical method involves either solvent extraction or solid phase extraction (SPE), the extraction should be performed immediately after sampling or after storing the sample refrigerated for a maximum of 24 hours.
Če analitična metoda vključuje bodisi ekstrakcijo s topili ali ekstrakcijo trdne faze (SPE), je treba ekstrakcijo opraviti nemudoma po vzorčenju ali po ohlajenem shranjevanju za največ 24 ur.
Depending on the sensitivity of the analytical method, larger sample volumes than those indicated in section 1.8.1 may be necessary.
Morda bodo potrebni volumni vzorcev, večji od prikazanih v oddelku 1.8.1, odvisno od občutljivosti analitične metode.
Simkins, S. and Alexander, M. (1984).
Simkins, S. in Alexander, M. (1984).
(in Swedish).
(v švedščini).
Bruce R.D. and Versteeg D.J.
Bruce R.D. in Versteeg D.J.
Brain P. and Cousens R. (1989).
Brain P. in Cousens R. (1989).
The sorbent system contains a front and a backup sorbent section.
Sorbentni sistem ima sprednji in pomožni sorbentni del.
Optional Cat.
neobvezna kat.
Apparatus to determine algal biomass. Cell count, which is the most frequently used surrogate parameter for algal biomass, may be made using an electronic particle counter, a microscope with counting chamber, or a flow cytometer.
Aparatura za določanje biomase alg: število celic, ki je najpogosteje uporabljen nadomestni parameter za biomaso alg, se lahko izvede z uporabo elektronskega števca delcev, mikroskopa s števno komoro ali pretočnega citometra.
The surface sediment can be prepared as follows: extract several sediment cores using a tube of transparent plastic, slice off the upper aerobic layers (from surface to a depth of max. 5 mm) immediately after sampling and pool them together.
Površinski sediment se lahko pripravi po naslednjem postopku: neposredno po vzorčenju se s cevko iz prosojne plastične mase izvleče več sredic sedimenta, odreže zgornje aerobne plasti (od površine do globine največ 5 mm), nato pa se sredice združijo.
For non-14C-labelled non-volatile test chemicals, loose cotton wool plugs that prevent contamination from air are suitable (see section 1.8.1) provided that any major degradation products are known to be non-volatile, and if indirect CO2 determination is used (see Appendix 3).
Za nehlapne preskusne kemikalije, ki niso označene s 14C, so primerni razrahljani vatirani čepi, ki preprečujejo onesnaženje iz zraka (glejte oddelek 1.8.1), pod pogojem, da je za poglavitne produkte razgradnje znano, da so nehlapni in da se uporablja posredno določevanje CO2 (glejte Dodatek 3).
Incubate the flasks at the selected temperature (see section 1.8.8.1).
Bučke inkubirajte pri izbrani temperaturi (glejte oddelek 1.8.8.1).
C: Pressure gauge D: Vacuum
C: Merilnik tlaka
= 1,0 mg/ml
= 1,0 mg/ml
= 2,32 mg/ml
= 2,32 mg/ml
= 3,0 mg/ml
= 3,0 mg/ml
concentrations tested: the nominal test concentrations and any results of analyses to determine the concentration of the test substance in the test vessels. The recovery efficiency of the method and the limit of quantification in the test matrix should be reported,
preskušene koncentracije: nominalne preskusne koncentracije in vsake rezultate analiz, da se določi koncentracija preskusne snovi v preskusnih posodah Poroča naj se o rekuperaciji metode in meji količinske določitve v preskusni matrici,
Series on Testing and Assessment, no. 23.
Series on Testing and Assessment, št. 23.
Draper, N.R. and Smith, H. (1981).
Draper, N.R. in Smith, H. (1981).
Ingerslev, F. and N. Nyholm.
Ingerslev, F. in N. Nyholm.
Environment Canada.
Environment Canada. (1993).
Huebert, D.B. and Shay J.M.
Huebert, D.B. in Shay J.M.
Test Method B.40 BIS. IN VITRO SKIN CORROSION: HUMAN SKIN MODEL TEST.
Test Method B.40 a, IN VITRO SKIN CORROSION: HUMAN SKIN MODEL TEST.
OECD TG 221 (2006) Lemna Sp.
OECD TG 221 (2006). Lemna Sp.
Sims I., Whitehouse P., and Lacey R. (1999).
Sims I., Whitehouse P., in Lacey R. (1999).
Test Method B.4. ACUTE TOXICITY; DERMAL IRRITATION/CORROSION.
Test Method B.4, ACUTE TOXICITY; DERMAL IRRITATION/CORROSION.
Test Method B.40. IN VITRO SKIN CORROSION: TRANSCUTANEOUS ELECTRICAL RESISTANCE TEST TER.
Test Method B.40, IN VITRO SKIN CORROSION: TRANSCUTANEOUS ELECTRICAL RESISTANCE TEST TER.
United Nations (UN) (2007). Globally Harmonized System of Classification and Labelling of Chemicals (GHS), Second revised edition, UN New York and Geneva, 2007.
United Nations (UN) (2007) Globally Harmonized System of Classification and Labelling of Chemicals (GHS), druga revidirana izdaja, ZN, New York in Ženeva, 2007.
OECD (2006). Test Guideline 435.
OECD (2006), Test Guideline 435.
Fentem, J.H., Briggs, D., Chesné, C., Elliot, G.R., Harbell, J.W., Heylings, J.R., Portes, P., Roguet, R., van de Sandt, J.J.M. & Botham, P. (2001). A prevalidation study on in vitro tests for acute skin irritation. Results and evaluation by the Management Team.
Fentem, J. H., Briggs, D., Chesné, C., Elliot, G. R., Harbell, J. W., Heylings, J. R., Portes, P., Roguet, R., van de Sandt, J. J. M. in Botham, P. (2001), A prevalidation study on in vitro tests for acute skin irritation.
Portes, P., Grandidier, M.H., Cohen, C. & Roguet, R.(2002). Refinement of the EPISKIN protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. Toxicology in Vitro 16, 765-770.
Portes, P., Grandidier, M. H., Cohen, C. in Roguet, R.(2002), Refinement of the EPISKIN protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study, Toxicology in Vitro, 16, 765–770.
Kandárová, H., Liebsch, M., Genschow, E., Gerner, I., Traue, D., Slawik, B. & Spielmann, H. (2004). Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX 21, 107-114.
Kandárová, H., Liebsch, M., Genschow, E., Gerner, I., Traue, D., Slawik, B. in Spielmann, H. (2004), Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests, ALTEX 21, 107–114.
Kandárová, H., Liebsch, M., Gerner, I., Schmidt, E., Genschow, E., Traue, D. & Spielmann H. (2005) The EpiDerm Test Protocol fort the Upcoming ECVAM Validation Study on In Vitro Skin Irritation Tests — An Assessment of the Performance of the Optimised Test. ATLA 33, 351-367.
Kandárová, H., Liebsch, M., Gerner, I., Schmidt, E., Genschow, E., Traue, D. in Spielmann H. (2005), The EpiDerm Test Protocol fort the Upcoming ECVAM Validation Study on In Vitro Skin Irritation Tests – An Assessment of the Performance of the Optimised Test, ATLA 33, 351–367.
Cotovio, J., Grandidier, M.-H., Portes, P., Roguet, R. & G. Rubinsteen. (2005). The In Vitro Acute Skin Irritation of Chemicals: Optimisation of the EPISKIN Prediction Model within the Framework of the ECVAM Validation Process. ATLA 33, 329-249.
Cotovio, J., Grandidier, M.–H., Portes, P., Roguet, R. in Rubinsteen, G. (2005), The In Vitro Acute Skin Irritation of Chemicals: Optimisation of the EPISKIN Prediction Model within the Framework of the ECVAM Validation Process, ATLA 33, 329–249.
Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J., Eskes, C., Roguet, R., Cotovió, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. and Zuang, V. (2007) The ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test. ATLA 35, 559-601.
Hoffmann, S., Liebsch, M., Botham, P., Fentem, J., Eskes, C., Roguet, R., Cotovió, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. in Zuang, V. (2007), The ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Report on the Validity of the EPISKIN and EpiDerm Assays and on the Skin Integrity Function Test, ATLA 35, 559–601.
Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. & Zuang. V (2007) ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Selection of Test Chemicals. ATLA 35, 603-619.
Eskes, C., Cole, T., Hoffmann, S., Worth, A., Cockshott, A., Gerner, I. in Zuang V. (2007), ECVAM International Validation Study on In Vitro Tests for Acute Skin Irritation: Selection of Test Chemicals, ATLA 35, 603–619.
EpiDerm™ SOP, Version 5.0 (October 2004). Draft Standard Operating Procedure.
EpiDerm™ SOP, izdaja 5.0 (oktober 2004), Draft Standard Operating Procedure.
Harvell, J.D., Lammintausta, K., Maibach H.I. (1995) Irritant contact dermatitis IN: Guin J.D. Practical Contact Dermatitis Mc Graw-Hill New York, pp 7-18
Harvell, J. D., Lamminstausta, K, Maibach H. I. (1995), Irritant contact dermatitis, v: Guin J. D., Practical Contact Dermatitis, Mc Graw-Hill New York, str. 7–18.
The test duration is normally 72 hours. However, shorter or longer test durations may be used, provided that all validity criteria in section 1.7 can be met.
Preskus ponavadi traja 72 ur. Preskus lahko traja tudi več ali manj časa, pod pogojem da so izpolnjena vsa merila za veljavnost, navedena v poglavju 1.7.
Although the operational requirements of different SEMs may vary, generally to obtain the best visibility and resolution, with relatively low atomic weight materials, accelerating voltages of 5-10 keV should be used with a small spot size setting and short working distance. As a linear traverse is being conducted, then a 0° tilt should be used to minimise re-focussing or, if the SEM has a eucentric stage, the eucentric working distance should be used.
Ker se izvaja linearni prehod, se priporoča uporaba naklona 0o za najmanjše potrebno ponovno fokusiranje ali, če je SEM v evcentričnem stanju, evcentrična delovna razdalja.
L., Billeck B. N. and Baron C. L. (1989).
L., Billeck B. N. in Baron C. L. (1989).
Skin irritation: The production of reversible damage to the skin following the application of a test substance for up to 4 hours. Skin irritation is a locally arising, non-immunogenic reaction, which appears shortly after stimulation (24).
Draženje kože: draženje kože je nastanek popravljive poškodbe kože po nanosu testne snovi za čas do 4 ur. Razdraženost kože je reakcija, ki je prisotna na posameznih mestih, ni imunogena in se pojavi kmalu po izpostavitvi kože draženju (24).
Zuang, V., Balls, M., Botham, P.A., Coquette, A., Corsini, E., Curren, R.D., Elliot, G.R., Fentem, J.H., Heylings, J.R., Liebsch, M., Medina, J., Roguet, R., van De Sandt, J.J.M., Wiemann, C. & Worth, A.(2002). Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation.
Zuang, V., Balls, M., Botham, P. A., Coquette, A., Corsini, E., Curren, R. D., Elliot, G. R., Fentem, J. H., Heylings, J. R., Liebsch, M., Medina, J., Roguet, R., van De Sandt, J. J. M., Wiemann, C. in Worth, A. (2002), Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation.
ECVAM Skin Irritation Task Force Report 2. ATLA 30,109-129.
ECVAM Skin Irritation Task Force Report 2, ATLA 30,109–129.
Hoffmann, S. (2006). ECVAM Skin Irritation Validation Study Phase II: Analysis of the Primary Endpoint MTT and the Secondary Endpoint IL1-α.
Hoffmann, S. (2006), ECVAM Skin Irritation Validation Study Phase II: Analysis of the Primary Endpoint MTT and the Secondary Endpoint IL1-α, str. 135 + priloge.
135 pp. + annexes. Available under Download Study Documents, at: http://ecvam.jrc.ec.europa.eu.
Na voljo pod Download Study Documents na spletni strani: http://ecvam.jrc.ec.europa.eu.
Cotovio, M.-H. Grandidier, D. Lelièvre, R. Roguet, E. Tinois-Tessonneaud, J. Leclaire (2007). In vitro acute skin irritancy of chemicals using the validated EPISKIN model in a tiered strategy — Results and performances with 184 cosmetic ingredients, AATEX, Special Issue-proceedings from WC6. Vol.14, 351-358.
Cotovio, J., Grandidier, M–H., Lelièvre, D., Roguet, R., Tinois-Tessonneaud, E., Leclaire, J. (2007), In vitro acute skin irritancy of chemicals using the validated EPISKIN model in a tiered strategy -Results and performances with 184 cosmetic ingredients, AATEX, Special Issue-proceedings from WC6, zvezek 14, 351–358.
EpiSkin™ SOP, Version 1.6 (January 2005). Validation of the EpiSkin Skin Irritation Test — 42 Hours Assay For The Prediction of Acute Skin Irritation of Chemicals.
EpiSkin™ SOP, izdaja 1.6 (januar 2005), Validation of the EpiSkin Skin Irritation Test – 42 Hours Assay For The Prediction of Acute Skin Irritation of Chemicals.
Exponentially growing test organisms are exposed to the test substance in batch cultures over a period of normally 72 hours. In spite of the relatively brief test duration, effects over several generations can be assessed.
Preskusni organizmi v eksponentni fazi rasti se v šaržnih kulturah izpostavijo preskusni snovi ponavadi za 72 ur. Kljub relativno kratkemu trajanju preskusa je mogoče oceniti učinke na več generacijah.
Commission Regulation (EC) No 762/2009
Uredba Komisije (ES) št. 762/2009
This Regulation shall enter into force on 21 August 2009.
Ta uredba začne veljati 21. avgusta 2009.
Commission Regulation (EC) No 763/2009
Uredba Komisije (ES) št. 763/2009
of 21 August 2009
z dne 21. avgusta 2009
This Regulation shall enter into force on 22 August 2009.
Ta uredba začne veljati 22. avgusta 2009.
Done at Brussels, 21 August 2009.
V Bruslju, 21. avgusta 2009
Commission Regulation (EC) No 764/2009
Uredba Komisije (ES) št. 764/2009
establishing a prohibition of fishing for cod in ICES zone IV; EC waters of IIa; that part of IIIa not covered by the Skagerrak and the Kattegat by vessels flying the flag of Sweden
o prepovedi ribolova na trsko v coni ICES IV, vodah ES cone IIa in delu cone IIIa, ki ni zajet v Skagerraku in Kattegatu, s plovili, ki plujejo pod zastavo Švedske
COD — Cod (Gadus morhua)
TRSKA – trska (Gadus morhua)
IV; EC waters of IIa; that part of IIIa not covered by the Skagerrak and the Kattegat
IV; vode ES cone IIa; del cone IIIa, ki ni zajet v Skagerraku in Kattegatu
Commission Regulation (EC) No 765/2009
Uredba Komisije (ES) št. 765/2009
establishing a prohibition of fishing for cod in Skagerrak by vessels flying the flag of the Netherlands
o prepovedi ribolova na trsko v Skagerraku s plovili, ki plujejo pod zastavo Nizozemske
18 June 2009
junija 2009
Commission Regulation (EC) No 766/2009
Uredba Komisije (ES) št. 766/2009
establishing a prohibition of fishing for plaice in Skagerrak by vessels flying the flag of the Netherlands
o prepovedi ribolova na morsko ploščo v Skagerraku s plovili, ki plujejo pod zastavo Nizozemske
Council Regulation (EC) No 43/2009 of 16 January 2009 fixing for 2009 the fishing opportunities and associated conditions for certain fish stocks and groups of fish stocks applicable in Community waters and for Community vessels, in waters where catch limitations are required [3], lays down quotas for 2009.
Uredba Sveta (ES) št. 43/2009 z dne 16. januarja 2009 o določitvi ribolovnih možnosti za leto 2009 in s tem povezanih pogojev za nekatere staleže rib in skupine staležev rib, ki se uporabljajo v vodah Skupnosti, in za plovila Skupnosti v vodah, kjer so potrebne omejitve ulova, določa kvote [3] za leto 2009.
12 June 2009
junij 2009
Regulation (EC) No 767/2009 of the European Parliament and of the Council
Uredba (ES) št. 767/2009 Evropskega parlamenta in Sveta
on the placing on the market and use of feed, amending European Parliament and Council Regulation (EC) No 1831/2003 and repealing Council Directive 79/373/EEC, Commission Directive 80/511/EEC, Council Directives 82/471/EEC, 83/228/EEC, 93/74/EEC, 93/113/EC and 96/25/EC and Commission Decision 2004/217/EC
o dajanju krme v promet in njeni uporabi, spremembi Uredbe (ES) št. 1831/2003 Evropskega parlamenta in Sveta in razveljavitvi Direktive Sveta 79/373/EGS, Direktive Komisije 80/511/EGS, direktiv Sveta 82/471/EGS, 83/228/EGS, 93/74/EGS, 93/113/ES in 96/25/ES ter Odločbe Komisije 2004/217/ES
The pursuit of a high level of protection of human and animal health is one of the fundamental objectives of food law, as laid down in Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety [3].
Doseganje visoke ravni varovanja zdravja ljudi in živali je eden od temeljnih ciljev živilske zakonodaje, kakor je določeno v Uredbi (ES) št. 178/2002 Evropskega parlamenta in Sveta z dne 28. januarja 2002 o določitvi splošnih načel in zahtevah živilske zakonodaje, ustanovitvi Evropske agencije za varnost hrane in postopkih, ki zadevajo varnost hrane [3].
That Regulation also established the farm-to-fork approach designating feed as a sensitive stage at the beginning of the food chain.
Navedena uredba je prav tako uvedla pristop „od vil do vilic“, s katerim je določila, da predstavlja krma občutljivo področje na začetku prehranske verige.
To ensure a high level of protection of public health is one of the fundamental objectives of this Regulation.
Eden glavnih ciljev te uredbe je zagotoviti visoko raven varovanja javnega zdravja.
The production of feed is an important end for European agricultural products, given that most of the materials used for the production of feed are agricultural products listed in Annex I to the Treaty.
Proizvodnja krme je pomemben cilj evropskih kmetijskih proizvodov glede na to, da večino snovi, ki se uporabljajo za proizvodnjo krme, predstavljajo kmetijski proizvodi iz Priloge I Pogodbe.
Furthermore, feed is of crucial significance for the 5 million livestock farmers in the Community because it represents the greatest expense.
Poleg tega je krma ključnega pomena za pet milijonov živinorejcev v Skupnosti, saj predstavlja največji strošek.
Feed may take the form of feed materials, compound feed, feed additives, premixtures or medicated feedingstuffs.
Krma je lahko v obliki posamičnih krmil, krmnih mešanic, krmnih dodatkov, premiksov ali medicirane krme.
The rules for the marketing of feed additives are set out in Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition [4] and for medicated feedingstuffs in Council Directive 90/167/EEC of 26 March 1990 laying down the conditions governing the preparation, placing on the market and use of medicated feedingstuffs in the Community [5].
Pravila za dajanje krmnih dodatkov v promet so določena v Uredbi (ES) št. 1831/2003 z dne 22. septembra 2003 o dodatkih za uporabo v prehrani živali [4], pravila za dajanje medicirane krme v promet pa v Direktivi Sveta 90/167/EGS z dne 26. marca 1990 o pogojih za proizvodnjo, dajanje na trg in uporabo medicirane krme v Skupnosti [5].
The existing legislation on the circulation and use of feed materials and compound feed, which includes pet food, namely Council Directive 79/373/EEC of 2 April 1979 on the circulation of compound feedingstuffs [6], Council Directive 93/74/EEC of 13 September 1993 on feedingstuffs intended for particular nutritional purposes [7] (dietetic feed), Council Directive 96/25/EC of 29 April 1996 on the circulation and use of feed materials [8] and Council Directive 82/471/EEC of 30 June 1982 concerning certain products used in animal nutrition [9] (bio-proteins), needs to be updated and replaced by a single regulation.
Posodobiti je treba veljavno zakonodajo o prometu s posamičnimi krmili in krmnimi mešanicami, vključno s hrano za živali, ter njihovi uporabi, t. j. Direktivo Sveta 79/373/EGS z dne 2. aprila 1979 o trženju krmnih mešanic [6], Direktivo Sveta 93/74/EGS z dne 13. septembra 1993 o krmi za posebne prehranske namene [7] („dietetični krmi“), Direktivo Sveta 96/25/ES z dne 29. aprila 1996 o obtoku posamičnih krmil [8] in Direktivo Sveta 82/471/EGS z dne 30. junija 1982 o nekaterih proizvodih, ki se uporabljajo v prehrani živali [9] („bioproteini“), ter jih nadomestiti z enotno uredbo.
In the interests of clarity, Council Directive 83/228/EEC of 18 April 1983 on the fixing of guidelines for the assessment of certain products used in animal nutrition [10] and Commission Directive 80/511/EEC of 2 May 1980 authorising, in certain cases, the marketing of compound feedingstuffs in unsealed packages or containers [11] should be repealed.
Zaradi jasnosti bi bilo treba razveljaviti Direktivo Sveta 83/228/EGS z dne 18. aprila 1983 o določanju smernic za ocenjevanje nekaterih proizvodov, ki se uporabljajo v prehrani živali [10], in Direktivo Komisije 80/511/EGS z dne 2. maja 1980 o trženju krmnih mešanic v nezaprti embalaži oziroma posodi [11], v nekaterih primerih.